Nasal administration of transforming growth factor-β1, induces dendritic cells and inhibits protracted-relapsing experimental allergic encephalomyelitis

Multiple Sclerosis

Volumn 5, Issue 3, 1999, Pages 184-191

  Ishikawa, Mikio ^a   Jin, Yuxuen ^a,b   Guo, Hong ^a,c   Link, Hans ^a   Xiao, Bao Guo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b FUDAN UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Apoptosis; Dendritic cell; Experimental allergic encephalomyelitis; Intranasal immunotherapy; Multiple sclerosis; Transforming growth factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON ANTIBODY; NITRIC OXIDE; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DENDRITIC CELL; HELPER CELL; INTRANASAL DRUG ADMINISTRATION; MACROPHAGE; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NONHUMAN; RAT; RELAPSE;

EID: 0033001779     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245899678846050     Document Type: Article

References (38)

1. Olsson T. (1995) Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144: 245-268.
2. Moses HL, Serra R. (1996) Regulation of differentiation by TGF-beta. Curr Opin Genet Dev 6: 581-586.
3. Strober W et al. (1997) Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18: 61-64.
4. Puolakkainen PA et al. (1995) The enhancement in wound healing by transforming growth factor-beta 1 (TGF-beta 1) depends on the topical delivery system. J Surg Res 58: 321-329.
5. Harpel JG, Metz CN, Kojima S, Rifkin DB. (1992) Control of transforming growth factor-β activity: latency vs. activation. Prog Growth Factor Res 4: 321-335.
6. Wahl SM. (1994) Transforming growth factor beta: the good, the bad, and the ugly. J Exp Med 180: 1587-1590.
7. Shull MM et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
8. Johns LD, Flanders KC, Ranges GE, Sriram S. (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 147: 1792-1796.
9. Kuruvilla AP et al. (1991) Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Immunology 88: 2918-2921.
10. Racke MK et al. (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 146: 3012-3017.
11. Santambrogia L et al. (1993) Studies on the mechanisms by which transforming growth factor-β (TGF-β) protects allergic encephalomyelitis. J Immunol 151: 1116-1127.
12. Xiao BG et al. (1998) Suppressive of murine acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low dose IL-10. J Neuroimmunol In press.
13. Deibler GE, Martenson RE, Kies MW. (1972) Large scale preparation of myelin basic protein from central nervous tissue of several mamalian species. Prep Biochem 2: 139-165.
14. Olsson T et al. (1990) Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon. J Clin Invest 86: 981-985.
15. Steinman RM, Kaplan G, Witman MD, Cohn ZA. (1979) Identification of a novel cell type in peripheral lymphoid organs of mice. J Exp Med 149: 1-16.
16. Riedl E, Strobl H, Majdic O, Knapp W. (1997) TGF-(1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J Immunol 158: 1591-1597.
17. Strobl H et al. (1996) TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol 157: 1499-1507.
18. Macatonia SE, Doherty TM, Knight SC, O'Garra A. (1993) Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150: 3755-3765.
19. Issazadeh S et al. (1994) Interferon-(, interleukin 4 and transforming growth factor-β in experimental allergic encephalomyelitis in Lewis rats; dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 40: 579-590.
20. Mustafa M et al. (1994) Alleles of both MHC class 1 and 2 regions have protective roles in MBP 63-88 induced EAE in rats. J Immunol 153: 3337-3344.
21. Tanuma N et al. (1997) Competitive PCR quantification of pro-and anti-inflammatory cytokine mRNA in the central nervous system during autoimmune encephalomyelitis. J Neuroimmunol 73: 197-206.
22. Ferber IA et al. (1996) Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis. J Immunol 156: 5-7.
23. Heremans H et al. (1996) Chronic relapsing experimental autoimune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon-gamma. Eur J Immunol 26: 2393-2398.
24. Lublin FD et al. (1993) Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 16: 267-274.
25. Lu L et al. (1996) Induction of nitric oxide synthase in mouse dendritic cells by interferon-γ, endotoxin and interaction with allogenic T cells: nitric oxide induction is associated with dendritic cell apoptosis. J Immunol 157: 3577-3586.
26. Bonham CA et al. (1996) Nitric oxide production by mouse bone marrow-derived dendritic cells. Transplantation 62: 1871-1877.
27. Zettl UK et al. (1997) Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol 178: 1-8.
28. Suss G, Shortman K. (1996) A subclass of dendritic cells kills CD4 Tcell via Fas/Fas-ligand induced apoptosis. J Exp Med 183: 1789-1796.
29. Nguyen KB, McCombe PA, Pender MP. (1994) Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis. J Autoimmunity 7: 145-152.
30. MacFarland HI et al. (1995) Amelioration of autoimmune reactions by antigen-induced apoptosis of T cells. Adv Exp Med Biol 383: 157-166.
31. Dowling P et al. (1997) Cell death and birth in multiple sclerosis brain. J Neurol Sci 149: 1-11.
32. Steinman RM, Witmer MD. (1978) Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc Natl Acad Sci USA 75: 5132-5136.
33. Metlay JP, Puré E, Steinman RM. (1989) Control of the immune response at the level of the antigen presenting cells: a comparison of the function of the dendritic cells and B lymphocytes. Ad Immunol 47: 45-116.
34. Pelfrey CM et al. (1995) Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J Immunol 154: 6191-6202.
35. Matyszak MK, Perry VH. (1996) The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neuroscience 74: 559-608.
36. Beauparlant P, Hiscott J. (1996) Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev 7: 175-190.
37. Krasteva M et al. (1998) Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 160: 1181-1190.
38. Smeltz RB, Swanborg RH. (1998) Concordance and contradiction concerning cytokines and chemokines in experimental demyelinating disease. J Neurosci Res 51: 147-153.